SALSA MLPA KIT P050-B2 CAH

Size: px
Start display at page:

Download "SALSA MLPA KIT P050-B2 CAH"

Transcription

1 SALSA MLPA KIT P050-B2 CAH Lot 0510, 0909, 0408: Compared to lot 0107, extra control fragments have been added at 88, 96, 100 and 105 nt. The 274 nt probe gives a higher signal in lot 0510 compared to previous lots. CONGENITAL ADRENAL HYPERPLASIA (CAH) results from a deficiency in one of the enzymes involved in cortisol biosynthesis. CAH affects about 1 in 5,000 births, with a carrier frequency of 1 in 35. As a result of defective cortisol synthesis, ACTH levels increase, resulting in overproduction and accumulation of cortisol precursors. This causes excessive production of adrenal androgens from early fetal life, resulting in virilization. In about 95% of cases, CAH is caused by deficiency of the 21-hydroxylating enzyme encoded by the CYP21A2 (CYP21) gene on chromosome 6p21.3. Other genes near CYP21A2 include the inactive pseudogene CYP21A1P (=CYP21P), the complement C4A, C4B, TNXB (Tenascin-XB) and its pseudogene TNXA. TNXA is a small duplicated part of the TNXB gene. Interestingly, the sequences of CYP21A2, CYP21A1P, C4A and C4B are almost identical. Orientation of genes from the 6p telomere to the centromere is as follows: C4A- CYP21A1P-TNXA-C4B-CYP21A2-TNXB-ATF6B(CREBL1). CAH due to 21-hydroxylase deficiency is unusual among genetic diseases in that approximately 95% of the mutant alleles are due to the recombination between a gene (CYP21A2) and its pseudogene (CYP21A1P). Approximately 20% of mutant alleles have DNA deletions of 30 kb that have been generated by unequal meiotic crossing-over, whereas 75% are gene conversions of deleterious mutations normally present in CYP21A1P which have been transferred to CYP21A2 (White and Speiser, 2000).. The P050 CAH probemix is designed to detect large deletions and large gene conversions in the CYP21A2, C4 and TNXB genes on 6p21.3. This P050-B2 CAH probemix contains 5 probes for CYP21A2 (exons 1, 3, 4, 6 and 8); among these are the 8 bp deletion, I172N, Cluster E6 and Q318X mutation. Furthermore, this P050-B2 CAH probemix contains 3 CYP21A1P-specific probes, 3 TNXB probes, 1 C4A probe, 1 C4B probe, and 1 probe for the CREBL1 gene located q-telomeric of TNXB. In addition, 2 other probes located on chromosome 6p21.3, 1 Y-chromosome specific probe (UTY gene) and 16 reference probes are included. This SALSA MLPA kit is designed to detect deletions/duplications of one or more exons of the aforementioned genes. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak area of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak area, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings. Finally, note that most defects in this gene are expected to be small mutations which will not be detected by this MLPA test. SALSA kits are sold by for research purposes and to demonstrate the possibilities of the MLPA technique. This kit is not CE/FDA certified for use in diagnostic procedures. SALSA MLPA kits are supplied with all necessary buffers and enzymes. Purchase of the SALSA MLPA test kits includes a limited license to use these products for research purposes. The use of this MLPA kit requires a thermocycler with heated lid and sequence type electrophoresis equipment. Different fluorescent PCR primers are available. The MLPA technique has been first described in Nucleic Acid Research 30, e57 (2002). Related SALSA MLPA kits P155 Ehlers-Danlos syndrome III & IV: contains probes for COL3A1, TNXB More information Website : info@mlpa.com (information & technical questions); order@mlpa.com (for orders) Mail : bv; Willem Schoutenstraat 6, 1057 DN Amsterdam, the Netherlands SALSA kit P050 CAH Page 1 of 6

2 P050 genes The TNXB gene spans 80 kb and has at least 43 exons. Disruption of both copies of TNXB is the cause of a recessive form of the Ehlers-Danlos syndrome (MIM ). Haploinsufficiency of the TNXB gene can cause the hypermobility type of Ehlers-Danlos syndrome (Zweers et al. 2003). The C4A and C4B genes both encode a functional complement protein. C4A is usually approximately 22 kb long, whereas the C4B gene is polymorphic in size, either 22 or 16 kb, due to the presence/absence of a 6 kb intron. The 2 proteins differ by only 4 amino acids. The A stands for the acidic version, the B for the basic version. About half of the rare C4A + C4B null genes are the result of DNA deletions, which can extend into the CYP21A2 gene. Null alleles of either the C4A or C4B loci are however very common, occurring in about 10 to 16% of unaffected people respectively. It has been reported that homozygous deficiency of C4A is associated with systemic lupus erythematosus and with type I diabetes mellitus; homozygous deficiency of C4B is associated with susceptibility to bacterial meningitis. The usual copy number in the white population of C4A + C4B is between 2 and 6 copies per cell. This diversity may be related to different intrinsic strengths among humans to defend themselves against infections and susceptibility to autoimmune diseases. Studies show that the frequency of the C4B null allele in young and old men is 17.6 and 3.4% respectively; suggesting the C4B null allele may be a negative factor for survival. Figure 1: A schematic representation of the chromosome 6p21.3 region. Data analysis The P050-B2 probemix contains 33 different MLPA probes with amplification products between 130 and 391 nt. In addition, it contains 9 control fragments generating an amplification product smaller than 120 nt: four DNA Quantity fragments (Q-fragments) at nt, three DNA denaturation control fragments (Dfragments) at nt, one X-fragment at 100 nt and one Y-fragment at 105 nt. More information on how to interpret observations on these control fragments can be found in the MLPA protocol. Data generated by this probemix can first be normalised intra-sample by dividing the peak area of each probe s amplification product by the total area of only the reference probes in this probemix (block normalisation). Secondly, inter-sample normalisation can be achieved by dividing the intra-normalised probe ratio in a sample by the average intra-normalised probe ratio of all reference samples. Please note that this type of normalisation assumes no changes occurred in the genomic regions recognised by the reference probes. Data normalisation should be performed within one experiment. Only samples purified by the same method should be compared. Confirmation of most exons deletions and amplifications can be done by e.g. Southern blotting, long range PCR, qpcr, FISH. Note that Coffalyser, the MLPA analysis tool developed at, can be downloaded free of charge from our website This probemix was developed by A.O.H. Nygren and J.P. Schouten at. In case the results obtained with this probemix lead to a scientific publication, it would be very much appreciated if the first probemix designer could be made a coauthor. Info/remarks/suggestions for improvement: info@mlpa.com. SALSA kit P050 CAH Page 2 of 6

3 Table 1. SALSA MLPA P050-B2 CAH probemix Length Chromosomal position SALSA MLPA probe (nt) Reference Other CAH Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 100 X-fragment: Specific for the X chromosome 105 Y-fragment: Specific for the Y chromosome 130 Reference probe L q LTA probe L p Reference probe L q Reference probe L q ± C4B probe L02586 C4B Exon ± Reference probe L p Reference probe L q * CYP21A2 probe L01507 Exon C4A probe L04177 C4A Exon Reference probe L q Reference probe L p CYP21A2 probe L04179 Exon CYP21A2 probe L01508 Exon Reference probe L p CYP21A2 probe L01509 Exon UTY probe L00464 Yq Reference probe L q Reference probe L q CYP21A1P(=CYP21P) probe L exon Reference probe L p CYP21A2 probe L04895 Exon TNXB probe L01515 Exon Reference probe L q TNXB probe L02588 Exon TNXB probe L01513 Exon Reference probe L q ATF6B probe (CREBL1) L01512 ATF6B 346 BAK probe L p CYP21A2P(=CYP21P) probe L04182 Exon ± Reference probe L p Reference probe L p ± CYP21A1P(=CYP21P) probe L04181 Intron Reference probe L q26 ± The 154 nt C4B probe, 160 nt and 364 nt reference probes and 382 nt CYP21A1P probe have been reported to be more variable. * The 172 nt probe can give false deletions as a SNP exists under the first G of the target sequence (underlined and bold in the sequence in the next table). The probe could also be influenced by the 8bp deletion located in exon 3. The 178 nt probe may be less reliable. The 210 nt CYP21A2 probe has been reported to detect the mutation I172N. The 229 nt and 283 nt probes could be influenced by the exon 6 mutation cluster. The 283 nt probe is influenced by a mutation in the pseudogene (mutation Q318X; 1996C>T) which can cause false duplications. Always confirm a single exon change by another method. The signal of the 274 reference probe is higher in lot 0510 than in previous lots. SALSA kit P050 CAH Page 3 of 6

4 Please note The C4A-C4B region has been found to be very variable. Teisberg et al. (1988) studied RFLP patterns in the C4 gene region, determining C4 haplotype pattern and C4 gene number. Among 76 haplotypes, 12 had 1 C4 gene, 58 had 2 C4 genes, and 6 had 3 C4 genes. All probes specific to the 6p21 region (but outside the 6p21.3 region) should not be used as reference probe since larger genomic rearrangements are known to occur within this region. Exon numbering might be different as compared to literature! Please notify us of any mistakes. The identity of the genes detected by the control probes is available on request: info@mlpa.com. Table 2. 6p21.3 specific probes arranged according to chromosomal location Length (nt) SALSA MLPA probe Exon L04177 C4A Exon L L L04894 CYP21A1P 5 Exon 1 CYP21A1P Intron 2 CYP21A1P Exon L02586 C4B Exon L L01507 Wildtype of exon 3 Delta 8 bp L01508 Wildtype of I172N mutation L01509 Wildtype of exon 6 cluster L04895 Wildtype of Q318X CYP21A2, 18 nt before exon 1, reverse CYP21A2 Exon 3 CYP21A2 Exon 4 CYP21A2 Exon 6 CYP21A2 Exon L01515 TNXB Exon L02588 TNXB Exon L01513 TNXB Exon L01512 ATF6B Exon 1 Complete Probe Target Sequences CCAGGACCCCTGTCCAGTGTTAGA- CAGGAGCATGCAGGGGGGTTTGGTGGGCAAT CCCAGGTCGGGGCGGACACCC- TTGCCTGCACGGGTGATGTGGAACCAGAAAG GGAAGCTCTTGGGGGGCATATCTTC- AGGAGAAGAAGCAGGTGTTGAGGAGGCAGAAGAAGGTC GGATTAAGCCTCAATCCTCTGCGGCA- GAGGGTCAGGAAGGGAGCTCTGCGGGGAG AAGGCCCCTGCGGACCTGCG- GGGTGTTGCCCACAACAACCTCATGGCAATGGCC CTTGACCCCACCTTCAGGTACCC -TCCCACCGACCCGCCCACAGAGTGGCCCTTTTCT CCCGGACCTGTCCTTGGGAGACT- ACTCCCTGCTCTGGAAAGCCCACAAGAAGCTCACCCGC CTCTCTCCTCACCTGCAGCATCAT- CTGTTACCTCACCTTCGGAGACAAGATCAAGGTGCCTCACAG CCCC GCAGGCCATAGAGAAGAGGGATCACAT- CGTGGAGATGCAGCTGAGGCAGCACAAGGTGGGACTGTA TCCCCAGATTCAGCAGCGACTGC- AGGAGGAGCTAGACCACGAACTGGGCCCTGGTGC CGTGGCTGAGGAGACCTCCAGCTCTCT- GCGCCTGTCCTGGACGGTAGCCCAGGGCCCCTTT CAGGCCAGTTCGACTCTTTTGTGGTCCAGTT- CAAGGACAAAGACGGGCCCCAGGTGGTGCCCGT GACGCCGCCCTCCCGGGGTT- GGGGACAGAGCAGGTGCAGAGGCACTGCAGCTGCTCG CGCGTTTCTTCACCGACAACCTGCTT- AGCCCGGAGGACTGGGGTCTGCAGAGTGAGGCAC Distance to next probe Note: Exon numbering used here may differ from literature! Complete probe sequences are available on request: info@mlpa.com. Please notify us of any mistakes: info@mlpa.com kb 0.8 kb 2.6 kb 20.0 kb 9.5 kb 0.8 kb 0.3 kb 0.3 kb 0.3 kb 6 kb 23.9 kb 38.0 kb 18.9 kb SALSA kit P050 CAH Page 4 of 6

5 SALSA MLPA kit P050-B2 CAH sample pictures , , ,36 164,66 159,27 192,45 220,25 256,35 247, ,72 91,39 133,37 152,78 170,32 177,34 201,51 209,65 282,47 299, ,43 85,94 100,88 139,99 183,93 229,31 239,31 264,32 335,87 318,45 292,98 308,50 373,89 345,11 363,31 327,60 351,18 390, , Dye Signal Size (nt) Figure 2. Capillary electrophoresis pattern from a sample of approximately 50 ng human male control DNA analyzed with SALSA MLPA kit P050-B2 CAH (lot 0510) , , ,93 128,41 152,85 164,73 159,31 192,50 220,24 256,30 247,65 170,38 209, ,99 91,44 96,53 133,43 140,07 177,40 183,98 201,55 229,31 264,26 299,33 282,43 318,45 292,92 308,53 335,89 351,23 363,36 373,91 327,61 345, ,60 390, Dye Signal Size (nt) Figure 3. Capillary electrophoresis pattern from a sample of approximately 50 ng human female control DNA analyzed with SALSA MLPA kit P050-B2 CAH (lot 0510). SALSA kit P050 CAH Page 5 of 6

6 Figure 4. Top: schematic representation of the 6p21.3 region. Double-headed arrows indicate the extent of deletions identified by MLPA. Bottom: Capillary electrophoresis pattern of four DNA samples analysed with the P050 CAH kit (lot 1005). a) male reference DNA; b) male CAH patient carrying a homozygous deletion of C4B and CYP21A2; c) male CAH patient carrying a homozygous deletion spanning exon 1-6 of CYP21A2; d) female with a homozygous deletion of C4A and CYP21A1P. 1, 3, 4, 6, 8 and 10 are peaks corresponding to the respective exons of CYP21A2. P1, P2 are CYP21A1P-specific probes; T1, T2, T3 are specific to TNXB; C4A and C4B to corresponding genes. Implemented Changes compared to the previous product description version. Version 25 (46) - Product description adapted to a new lot (lot number added, small changes in Table 1 and 2, new picture included). - Small changes of probe lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products. Version 24 (43) - Altered product description to incorporate a new lot (lot number added, new picture included). - Small textual changes made on page 1. - Notes added for the 364 nt and 211 nt probes on page 3, Table 1. Version 23 - The text This SALSA MLPA kit is designed on page 1 has been modified. - Several textual changes have been made to Table 2. - The CREBL1 gene name has changed to ATF6B. - Warnings have been added for 154,160, 172,178 and 382 nt probes on page 3, Table 1. - Tables have been numbered. - Data analysis method has been modified. SALSA kit P050 CAH Page 6 of 6

MRC-Holland MLPA. Description version 08; 30 March 2015

MRC-Holland MLPA. Description version 08; 30 March 2015 SALSA MLPA probemix P351-C1 / P352-D1 PKD1-PKD2 P351-C1 lot C1-0914: as compared to the previous version B2 lot B2-0511 one target probe has been removed and three reference probes have been replaced.

More information

MRC-Holland MLPA. Description version 14; 28 September 2016

MRC-Holland MLPA. Description version 14; 28 September 2016 SALSA MLPA probemix P279-B3 CACNA1A Lot B3-0816. As compared to version B2 (lot B2-1012), one reference probe has been replaced and the length of several probes has been adjusted. Voltage-dependent calcium

More information

MRC-Holland MLPA. Description version 08; 07 May 2015

MRC-Holland MLPA. Description version 08; 07 May 2015 mix P185-C1 Intersex Lot C1-0611: As compared to the previous version B2 (lot B2-0311), s for CYP21A2 have been removed and s for the CXorf21 gene as well as additional s for NR0B1, NR5A1 and the Y chromosome

More information

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted.

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted. mix P169-C2 HIRSCHSPRUNG-1 Lot C2-0915. As compared to version C1 (lot C1-0612), the length of one has been adjusted. Hirschsprung disease (HSCR), or aganglionic megacolon, is a congenital disorder characterised

More information

MRC-Holland MLPA. Description version 12; 13 January 2017

MRC-Holland MLPA. Description version 12; 13 January 2017 SALSA MLPA probemix P219-B3 PAX6 Lot B3-0915: Compared to version B2 (lot B2-1111) two reference probes have been replaced and one additional reference probe has been added. In addition, one flanking probe

More information

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced. mix P241-D2 MODY mix 1 Lot D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent diabetes

More information

SALSA MLPA KIT P060-B2 SMA

SALSA MLPA KIT P060-B2 SMA SALSA MLPA KIT P6-B2 SMA Lot 111, 511: As compared to the previous version B1 (lot 11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). Please note that, in contrast to the

More information

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted.

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted. mix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four s have been adjusted. The sex-determining region on chromosome Y (SRY) is the most important

More information

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix. SALSA MLPA KIT P045-B2 BRCA2/CHEK2 Lot 0410, 0609. As compared to version B1, four reference probes have been replaced and extra control fragments at 100 and 105 nt (X/Y specific) have been included. New:

More information

MRC-Holland MLPA. Description version 29;

MRC-Holland MLPA. Description version 29; SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,

More information

MRC-Holland MLPA. Description version 29; 31 July 2015

MRC-Holland MLPA. Description version 29; 31 July 2015 SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082

More information

MRC-Holland MLPA. Description version 18; 09 September 2015

MRC-Holland MLPA. Description version 18; 09 September 2015 SALSA MLPA probemix P090-A4 BRCA2 Lot A4-0715, A4-0714, A4-0314, A4-0813, A4-0712: Compared to lot A3-0710, the 88 and 96 nt control fragments have been replaced (QDX2). This product is identical to the

More information

MRC-Holland MLPA. Description version 19;

MRC-Holland MLPA. Description version 19; SALSA MLPA probemix P6-B2 SMA Lot B2-712, B2-312, B2-111, B2-511: As compared to the previous version B1 (lot B1-11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). SPINAL

More information

MRC-Holland MLPA. Description version 30; 06 June 2017

MRC-Holland MLPA. Description version 30; 06 June 2017 SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0517, C1-0114. As compared to the previous B2 version (lot B2-0813, B2-0912), 11 target probes are replaced or added, and 10 new reference probes are

More information

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced. mix P241-D2 MODY mix 1 Lot D2-0716, D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent

More information

MRC-Holland MLPA. Description version 07; 26 November 2015

MRC-Holland MLPA. Description version 07; 26 November 2015 SALSA MLPA probemix P266-B1 CLCNKB Lot B1-0415, B1-0911. As compared to version A1 (lot A1-0908), one target probe for CLCNKB (exon 11) has been replaced. In addition, one reference probe has been replaced

More information

SALSA MLPA probemix P315-B1 EGFR

SALSA MLPA probemix P315-B1 EGFR SALSA MLPA probemix P315-B1 EGFR Lot B1-0215 and B1-0112. As compared to the previous A1 version (lot 0208), two mutation-specific probes for the EGFR mutations L858R and T709M as well as one additional

More information

MRC-Holland MLPA. Description version 08; 18 November 2016

MRC-Holland MLPA. Description version 08; 18 November 2016 SALSA MLPA probemix P122-D1 NF1 AREA Lot D1-1016. As compared to lot C2-0312, four probes in the NF1 area and one reference probe have been removed, four reference probes have been replaced and several

More information

MRC-Holland MLPA. Description version 06; 23 December 2016

MRC-Holland MLPA. Description version 06; 23 December 2016 SALSA MLPA probemix P417-B2 BAP1 Lot B2-1216. As compared to version B1 (lot B1-0215), two reference probes have been added and two target probes have a minor change in length. The BAP1 (BRCA1 associated

More information

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B1-0613. The purpose of the P372 probemix is to further investigate results found with the P245 Microdeletion Syndromes-1A probemix. The

More information

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment). SALSA MLPA probemix P343-C3 Autism-1 Lot C3-1016. As compared to version C2 (lot C2-0312) five reference probes have been replaced, one reference probe added and several lengths have been adjusted. Warning:

More information

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509 mix P371-A1 Microdeletion Syndromes 5 Lot A1-0509 The purpose of the P371 mix is to further investigate results found with the P245 Microdeletion mix. The P245 mix provides a possibility to screen samples

More information

MRC-Holland MLPA. Description version 13;

MRC-Holland MLPA. Description version 13; SALSA MLPA probemix P027-C1 Uveal Melanoma Lot C1-0211: A large number of probes have been replaced by other probes in the same chromosomal regions as compared to previous lots, and several reference probes

More information

P323-B1 CDK4-HMGA2-MDM2

P323-B1 CDK4-HMGA2-MDM2 SALSA MLPA probemix P323-B1 CDK4-HMGA2-MDM2 Lot B1-0714, B1-0711. As compared to previous test version (lot A1-0508), this probemix has been completely redesigned. Probes for HMGA2 and several other genes

More information

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A1-1011. This SALSA MLPA probemix is for basic research and intended for experienced MLPA users only! This probemix enables you to quantify genes

More information

MRC-Holland MLPA. Description version 06; 07 August 2015

MRC-Holland MLPA. Description version 06; 07 August 2015 SALSA MLPA probemix P323-B1 CDK4-HMGA2-MDM2 Lot B1-0711. As compared to version A1 (test version sent to test labs), this product has been completely redesigned. Probes for HMGA2 and several other genes

More information

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 The Mismatch Repair (MMR) system is critical for the maintenance of genomic stability. MMR increases the fidelity of DNA

More information

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53.

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53. SALSA MLPA probemix P056-C1 TP53 Lot C1-0215 & lot C1-0214. As compared to version B1 (lot B1-1011) most of the reference and flanking probes have been replaced and several have been added. Furthermore,

More information

PRADER WILLI/ANGELMAN

PRADER WILLI/ANGELMAN SALSA MS-MLPA probemix ME028-B2 PRADER WILLI/ANGELMAN Lot B2-0811: As compared to version B1 (lot B1-0609, B1-1108), the 88 and 96 nt control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME

More information

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109 SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109 This P078-B1 Breast Tumour probemix contains probes for several genes (including ERBB2, BIRC5, MYC, TOP2A, ESR1, MTDH, CCND1, CCNE1, EGFR and C11orf30)

More information

MRC-Holland MLPA. Description version 52; 22 July 2015

MRC-Holland MLPA. Description version 52; 22 July 2015 SALSA MS-MLPA probemix ME028-B2 Prader-Willi/Angelman Lot B2-0413, lot B2-0811. As compared to version B1 (lot B1-0609), the control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME (PWS) and

More information

SALSA MLPA probemix P383-A1 T-ALL Lot A

SALSA MLPA probemix P383-A1 T-ALL Lot A SALSA MLPA probemix P383-A1 T-ALL Lot A1-0213. T-lineage acute lymphoblastic leukaemia (T-ALL) is a clonal malignant disorder of immature T-cells, which accounts for about 15% of paediatric and 25% of

More information

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B1-0916 and B1-0713. Copy number changes of the human chromosome 8 are common in many types of tumours. In most cases, losses of 8p sequences and gains of 8q

More information

MRC-Holland MLPA. Description version 23; 15 February 2018

MRC-Holland MLPA. Description version 23; 15 February 2018 SALSA MLPA probemix P225-D2 PTEN Lot D2-0315. As compared to the previous version (lot D1-0613), one probe has a small change in length but no change in the sequence detected. PTEN is a tumour suppressor

More information

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length.

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length. SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length. This SALSA probemix is for basic research only! This

More information

MRC-Holland MLPA. Description version 05; 03 April 2019

MRC-Holland MLPA. Description version 05; 03 April 2019 SALSA MLPA probemix ME012-A1 MGMT-IDH1-IDH2 Lot A1-1215. Glioblastoma, the most common malignant primary brain tumour, is characterised by aggressive behaviour and a poor survival. Hypermethylation in

More information

CYP21A2 Mutations Found in Congenital Adrenal Hyperplasia Patients in the California Population

CYP21A2 Mutations Found in Congenital Adrenal Hyperplasia Patients in the California Population CYP21A2 Mutations Found in Congenital Adrenal Hyperplasia Patients in the California Population Christopher N. Greene, Ph.D. Newborn Screening and Molecular Biology Branch National Center for Environmental

More information

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol. Product Description SALSA Probemix P055-D1 PAH To be used with the MLPA General Protocol. Version D1. For complete product history see page 7. Catalogue numbers: P055-025R: SALSA MLPA probemix P055 PAH,

More information

MRC-Holland MLPA. Description version 28; 4 January 2018

MRC-Holland MLPA. Description version 28; 4 January 2018 SALSA MLPA probemix ME011-B3 Mismatch Repair genes Lot B3-1017 and B3-0715. As compared to the previous version B2 (lot B2-0614), one probe has a small change in length but no change in the sequence detected.

More information

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol. Product Description SALSA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol. Version C2. As compared to version C1, three reference probes have been replaced and the lengths of

More information

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Product Description SALSA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Version C1. As compared to version B3, the probes for the BRCA2 upstream region and exons 8, 11, 12, 19

More information

MRC-Holland MLPA. Description version 10; 06 April 2018

MRC-Holland MLPA. Description version 10; 06 April 2018 Description version ; 6 April 8 mix P36-B Y-Chromosome Microdeletions Lot B-5. As compared to version A (Lot A-), all probes f DPY9L, one probe f RBMYCP and one probe f KDM5D have been removed, and one

More information

MRC-Holland MLPA. Description version 23; 26 January 2017

MRC-Holland MLPA. Description version 23; 26 January 2017 SALSA MLPA probemix ME024-B2 9p21 CDKN2A/2B region Lot B2-0615. As compared to the previous version B1 (lot B1-0411), one flanking probe is redesigned, two reference probes are replaced, and several probes

More information

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol. Product Description SALSA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol. Version C1. For complete product history see page 7. Catalogue numbers: P138-025R: SALSA MLPA probemix

More information

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol. Product Description SALSA MS- Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol. Version C1. For complete product history see page 9. Catalogue numbers: ME028-025R: SALSA

More information

MRC-Holland MLPA. Description version 15;

MRC-Holland MLPA. Description version 15; probemix P036-E1 HUMAN TELOMERE-3 Lot E1-0910, E1-1208, E1-0808. As compared to version D2 (lot D2-0408), the probes for 1p and 4q have been replaced. Approximately 3-8% of all cases of mental retardation

More information

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced.

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced. SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced. MENTAL RETARDATION is caused by aberrant copy numbers of subtelomeric

More information

Development of a Multiplex CYP21A2 Genotyping Assay for Congenital Adrenal Hyperplasia Screening

Development of a Multiplex CYP21A2 Genotyping Assay for Congenital Adrenal Hyperplasia Screening Development of a Multiplex CYP21A2 Genotyping Assay for Congenital Adrenal Hyperplasia Screening Christopher N. Greene, Ph.D. Newborn Screening and Molecular Biology Branch National Center for Environmental

More information

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol. Product Description SALSA MS- Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol. Version C1. As compared to the previous version (lot B3-1017), this probemix has been

More information

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Product Description SALSA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Version C1. As compared to version B3, the probes for the BRCA2 upstream region and exons 8, 11, 12, 19

More information

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol. Product Description SALSA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol. Version F2. Compared to version F1, two reference probes have been replaced and the 118 nt Y fragment has been

More information

Brief Communication Diagnostic Genetics

Brief Communication Diagnostic Genetics Brief Communication Diagnostic Genetics Ann Lab Med 2015;35:535-539 http://dx.doi.org/10.3343/alm.2015.35.5.535 ISSN 2234-3806 eissn 2234-3814 CYP21A2 Mutation Analysis in Korean Patients With Congenital

More information

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Product Description SALSA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Version D1. For a complete product history see page 11. Catalogue numbers: P002-025R: SALSA MLPA probemix P002

More information

MODULE NO.14: Y-Chromosome Testing

MODULE NO.14: Y-Chromosome Testing SUBJECT Paper No. and Title Module No. and Title Module Tag FORENSIC SIENCE PAPER No.13: DNA Forensics MODULE No.21: Y-Chromosome Testing FSC_P13_M21 TABLE OF CONTENTS 1. Learning Outcome 2. Introduction:

More information

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Product Description SALSA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Version D1. As compared to version C2, 12 extra BRCA1 probes and 3 probes for exon 24 have been included, and

More information

A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia

A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia HUMAN MUTATION Mutation in Brief #247(1999) Online MUTATION IN BRIEF A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia Klaus Kapelari 1, Zahra Ghanaati

More information

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant

More information

The Human Major Histocompatibility Complex

The Human Major Histocompatibility Complex The Human Major Histocompatibility Complex 1 Location and Organization of the HLA Complex on Chromosome 6 NEJM 343(10):702-9 2 Inheritance of the HLA Complex Haplotype Inheritance (Family Study) 3 Structure

More information

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our 1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented

More information

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol. Product Description SALSA Probemix P250-B2 DiGeorge To be used with the MLPA ral Protocol. Version B2. As compared to version B1, the control fragments have been adjusted. For complete product history

More information

Sharan Goobie, MD, MSc, FRCPC

Sharan Goobie, MD, MSc, FRCPC Sharan Goobie, MD, MSc, FRCPC Chromosome testing in 2014 Presenter Disclosure: Sharan Goobie has no potential for conflict of interest with this presentation Objectives Review of standard genetic investigations

More information

Elucigene Male Factor Infertility Products Guide to Interpretation

Elucigene Male Factor Infertility Products Guide to Interpretation Elucigene Male Factor Infertility Products Guide to Interpretation Manufactured by: Elucigene Diagnostics Citylabs Nelson Street Manchester M13 9NQ For Sales, Customer Service and Technical Support:- T:

More information

MRC-Holland MLPA. Description version 24;

MRC-Holland MLPA. Description version 24; SALSA MLPA KIT P245-A2 Microdeletion Syndromes-1 Lot 0909, 0209, 1008. As compared to lot 1207, two extra control fragments at 100 and 105 nt have been added (X and Y-specific). The 108 nt Y probe has

More information

Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters

Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters XXXth International Symposium on Technical Innovations in Laboratory Hematology Honolulu, Hawaii

More information

Certificate of Analysis

Certificate of Analysis COA Version 01; Issued on 30 June 2017 (v02) Certificate of Analysis SALSA probemix P064 Microdeletion Syndromes-1B Catalogue # Product name P064-025R, P064-50R, P064-100R Probemix P064 Microdeletion Syndromes-1B

More information

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits?

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits? corebio II - genetics: WED 25 April 2018. 2018 Stephanie Moon, Ph.D. - GWAS After this class students should be able to: 1. Compare and contrast methods used to discover the genetic basis of traits or

More information

Introduction to Genetics

Introduction to Genetics Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist

More information

Supplementary methods:

Supplementary methods: Supplementary methods: Primers sequences used in real-time PCR analyses: β-actin F: GACCTCTATGCCAACACAGT β-actin [11] R: AGTACTTGCGCTCAGGAGGA MMP13 F: TTCTGGTCTTCTGGCACACGCTTT MMP13 R: CCAAGCTCATGGGCAGCAACAATA

More information

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol. Product Description SALSA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol. Version C2. Small change in sequence of two probes. For complete product history see page

More information

Chromosome Structure & Recombination

Chromosome Structure & Recombination Chromosome Structure & Recombination (CHAPTER 8- Brooker Text) April 4 & 9, 2007 BIO 184 Dr. Tom Peavy Genetic variation refers to differences between members of the same species or those of different

More information

BIOL2005 WORKSHEET 2008

BIOL2005 WORKSHEET 2008 BIOL2005 WORKSHEET 2008 Answer all 6 questions in the space provided using additional sheets where necessary. Hand your completed answers in to the Biology office by 3 p.m. Friday 8th February. 1. Your

More information

Phenylketonuria (PKU) the Biochemical Basis. Biol 405 Molecular Medicine

Phenylketonuria (PKU) the Biochemical Basis. Biol 405 Molecular Medicine Phenylketonuria (PKU) the Biochemical Basis Biol 405 Molecular Medicine PKU a history In 1934 Følling identified a clinical condition - imbecillitas phenylpyruvica. Mental retardation associated with this

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Invasive Prenatal (Fetal) Diagnostic Testing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: invasive_prenatal_(fetal)_diagnostic_testing 12/2014 3/2018

More information

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin

More information

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.

More information

Low Proportion of Whole Exon Deletions Causing Phenylketonuria in Denmark and Germany

Low Proportion of Whole Exon Deletions Causing Phenylketonuria in Denmark and Germany HUMAN MUTATION Mutation in Brief #952 (2007) Online MUTATION IN BRIEF Low Proportion of Whole Exon Deletions Causing Phenylketonuria in Denmark and Germany Lisbeth Birk Møller 1 *, Anders O.H. Nygren 2,

More information

Abstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 10 December 2003

Abstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online;   on web 10 December 2003 RBMOnline - Vol 8. No 2. 224-228 Reproductive BioMedicine Online; www.rbmonline.com/article/1133 on web 10 December 2003 Article Preimplantation genetic diagnosis for early-onset torsion dystonia Dr Svetlana

More information

Genetics and Genomics in Endocrinology

Genetics and Genomics in Endocrinology Genetics and Genomics in Endocrinology Dr. Peter Igaz MD MSc PhD 2 nd Department of Medicine Faculty of Medicine Semmelweis University Genetics-based endocrine diseases I. Monogenic diseases: Multiple

More information

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) 22q11.2 DELETION SYNDROME Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) Genomic disorders GENOMICS DISORDERS refers to those diseases

More information

Human inherited diseases

Human inherited diseases Human inherited diseases A genetic disorder that is caused by abnormality in an individual's DNA. Abnormalities can range from small mutation in a single gene to the addition or subtraction of a whole

More information

CHROMOSOMAL MICROARRAY (CGH+SNP)

CHROMOSOMAL MICROARRAY (CGH+SNP) Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due

More information

Genome 371, Autumn 2018 Quiz Section 9: Genetics of Cancer Worksheet

Genome 371, Autumn 2018 Quiz Section 9: Genetics of Cancer Worksheet Genome 371, Autumn 2018 Quiz Section 9: Genetics of Cancer Worksheet All cancer is due to genetic mutations. However, in cancer that clusters in families (familial cancer) at least one of these mutations

More information

Counsyl Foresight Carrier Screen. Utmost confidence in every result

Counsyl Foresight Carrier Screen. Utmost confidence in every result Counsyl Foresight Carrier Screen Utmost confidence in every result EXTENDING THE BENEFITS OF CARRIER SCREENING Elevate quality of care with expanded carrier screening (ECS) Carrier screening is used to

More information

Lecture 17: Human Genetics. I. Types of Genetic Disorders. A. Single gene disorders

Lecture 17: Human Genetics. I. Types of Genetic Disorders. A. Single gene disorders Lecture 17: Human Genetics I. Types of Genetic Disorders A. Single gene disorders B. Multifactorial traits 1. Mutant alleles at several loci acting in concert C. Chromosomal abnormalities 1. Physical changes

More information

Chapter 1 : Genetics 101

Chapter 1 : Genetics 101 Chapter 1 : Genetics 101 Understanding the underlying concepts of human genetics and the role of genes, behavior, and the environment will be important to appropriately collecting and applying genetic

More information

Variations in Chromosome Structure & Function. Ch. 8

Variations in Chromosome Structure & Function. Ch. 8 Variations in Chromosome Structure & Function Ch. 8 1 INTRODUCTION! Genetic variation refers to differences between members of the same species or those of different species Allelic variations are due

More information

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Application Note Authors John McGuigan, Megan Manion,

More information

Genomic structural variation

Genomic structural variation Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural

More information

Single Gene (Monogenic) Disorders. Mendelian Inheritance: Definitions. Mendelian Inheritance: Definitions

Single Gene (Monogenic) Disorders. Mendelian Inheritance: Definitions. Mendelian Inheritance: Definitions Single Gene (Monogenic) Disorders Mendelian Inheritance: Definitions A genetic locus is a specific position or location on a chromosome. Frequently, locus is used to refer to a specific gene. Alleles are

More information

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)

More information

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014 Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical

More information

p.r623c p.p976l p.d2847fs p.t2671 p.d2847fs p.r2922w p.r2370h p.c1201y p.a868v p.s952* RING_C BP PHD Cbp HAT_KAT11

p.r623c p.p976l p.d2847fs p.t2671 p.d2847fs p.r2922w p.r2370h p.c1201y p.a868v p.s952* RING_C BP PHD Cbp HAT_KAT11 ARID2 p.r623c KMT2D p.v650fs p.p976l p.r2922w p.l1212r p.d1400h DNA binding RFX DNA binding Zinc finger KMT2C p.a51s p.d372v p.c1103* p.d2847fs p.t2671 p.d2847fs p.r4586h PHD/ RING DHHC/ PHD PHD FYR N

More information

Exam #2 BSC Fall. NAME_Key correct answers in BOLD FORM A

Exam #2 BSC Fall. NAME_Key correct answers in BOLD FORM A Exam #2 BSC 2011 2004 Fall NAME_Key correct answers in BOLD FORM A Before you begin, please write your name and social security number on the computerized score sheet. Mark in the corresponding bubbles

More information

An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice

An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice Mei-Yi Wu 1 *, Ming Jiang 1, Xiaodong Zhai 2, Arthur L. Beaudet 2, Ray-Chang Wu 1 * 1 Department of

More information

Introduction to Cancer Biology

Introduction to Cancer Biology Introduction to Cancer Biology Robin Hesketh Multiple choice questions (choose the one correct answer from the five choices) Which ONE of the following is a tumour suppressor? a. AKT b. APC c. BCL2 d.

More information

Whole-genome detection of disease-associated deletions or excess homozygosity in a case control study of rheumatoid arthritis

Whole-genome detection of disease-associated deletions or excess homozygosity in a case control study of rheumatoid arthritis HMG Advance Access published December 21, 2012 Human Molecular Genetics, 2012 1 13 doi:10.1093/hmg/dds512 Whole-genome detection of disease-associated deletions or excess homozygosity in a case control

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi: 1.138/nature8645 Physical coverage (x haploid genomes) 11 6.4 4.9 6.9 6.7 4.4 5.9 9.1 7.6 125 Neither end mapped One end mapped Chimaeras Correct Reads (million ns) 1 75 5 25 HCC1187 HCC1395 HCC1599

More information

Introduction to LOH and Allele Specific Copy Number User Forum

Introduction to LOH and Allele Specific Copy Number User Forum Introduction to LOH and Allele Specific Copy Number User Forum Jonathan Gerstenhaber Introduction to LOH and ASCN User Forum Contents 1. Loss of heterozygosity Analysis procedure Types of baselines 2.

More information

Dianne Keen-Kim,* Joy B. Redman, Reno U. Alanes, Michele M. Eachus,* Robert C. Wilson, Maria I. New, Jon M. Nakamoto,* and Raymond G.

Dianne Keen-Kim,* Joy B. Redman, Reno U. Alanes, Michele M. Eachus,* Robert C. Wilson, Maria I. New, Jon M. Nakamoto,* and Raymond G. Journal of Molecular Diagnostics, Vol. 7, No. 2, May 2005 Copyright American Society for Investigative Pathology and the Association for Molecular Pathology Validation and Clinical Application of a Locus-

More information

Article Pre-embryonic diagnosis for Sandhoff disease

Article Pre-embryonic diagnosis for Sandhoff disease RBMOnline - Vol 12. No 3. 2006 328-333 Reproductive BioMedicine Online; www.rbmonline.com/article/2100 on web 9 January 2006 Article Pre-embryonic diagnosis for Sandhoff disease Dr Anver Kuliev received

More information